The acute treatment of episodic and chronic migraine in the USA.
about
Didactic migraine education in US doctor of pharmacy programs.Headache and Health-Related Job Loss among Disadvantaged WomenAssociation of μ-Opioid Activation in the Prefrontal Cortex with Spontaneous Migraine Attacks - Brief Report I.Refractory migraine in a headache clinic population.Targeting TRP channels for novel migraine therapeutics.Migraine: treatments, comorbidities, and quality of life, in the USA.A review of current European treatment guidelines for migraineMeeting acute migraine treatment needs through novel treatment formulations.Triptan persistency among newly initiated users in a pharmacy claims database.The paradoxical effects of analgesics and the development of chronic migraine.Taking the negative view of current migraine treatments: the unmet needs.Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse.Triptan use in Australia 1997-2015: A pharmacoepidemiological study.Lagniappe: the impact of headache disorders in America.Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.Effect of Different Meditation Types on Migraine Headache Medication Use.Prescription patterns in preventive and abortive migraine medication.Knowledge about and use of pharmacological and non-pharmacological headache therapies
P2860
Q33690536-61352432-3959-4459-966F-ED83F94450DEQ33749778-900FCB04-BE6F-4B23-AB0B-21A763E34ACEQ33949018-F5D4F252-3632-475F-B24C-C1C6247166C9Q33977598-4A5C7CF1-5E33-4D37-BF53-DA5E284B1995Q34555756-40CF20FC-8231-4954-98DB-8AD5150C61CBQ35966310-D052BF97-D484-45FE-84AC-B15B5922260EQ36260873-5B0AF675-3CBD-435F-AADA-FB98D94B65B8Q37739586-F9E25AD8-7F3C-42BF-B856-C23B65721473Q37799448-C9EB9BFD-6A74-4B25-B2A8-4495EA2182F6Q37900861-5AA781AF-825B-4875-B07D-AA48391CFC35Q38004092-C3B3D755-9E29-49AC-8F4C-95C3B75098EFQ38476100-04CDE920-DB4A-4DC9-BC2F-0359B815FC02Q39017558-5240232B-0138-4689-9C0B-3D1E5F3843B4Q39238901-273A1420-6499-4DCE-9FBD-6DA36DD45C80Q39255809-32FBFB1C-3A2F-4F14-8367-E96C96FC6E1CQ45051412-D5C78DC0-2E29-4DA7-867C-F0A76930F595Q46130867-D7A9F092-DF6E-4D89-880B-E19DE8E86E96Q46698001-10548522-F6D3-4A12-B9BA-39B924F0068EQ48041121-DB2724E2-7127-4FD7-8F2E-7BB029F76692Q50990714-D36636B8-D58B-4EA2-A3AE-53EA8336ECB1Q57992359-D5801107-DED3-4CD2-9D26-0FE5601BADBB
P2860
The acute treatment of episodic and chronic migraine in the USA.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The acute treatment of episodic and chronic migraine in the USA.
@en
The acute treatment of episodic and chronic migraine in the USA.
@nl
type
label
The acute treatment of episodic and chronic migraine in the USA.
@en
The acute treatment of episodic and chronic migraine in the USA.
@nl
prefLabel
The acute treatment of episodic and chronic migraine in the USA.
@en
The acute treatment of episodic and chronic migraine in the USA.
@nl
P2093
P2860
P1433
P1476
The acute treatment of episodic and chronic migraine in the USA.
@en
P2093
P2860
P304
P356
10.1111/J.1468-2982.2008.01819.X
P407
P577
2009-02-13T00:00:00Z